New analysis suggests patented NR may influence biological aging in skeletal muscle – but researchers say the science is still unfolding.
For years, the conversation around NAD+ has largely centered on energy. As levels of this essential cellular molecule decline with age, so too does the body’s ability to repair itself and maintain healthy function, making NAD+ restoration one of the most closely watched areas in longevity science. Now, Niagen Bioscience has added another piece to that puzzle.
The company has announced the publication of a peer-reviewed analysis in Aging Cell suggesting that supplementation with its patented nicotinamide riboside (NR), marketed as Niagen, was associated with improvements in a muscle-specific marker of biological aging. While the findings stop short of proving that NR slows aging, they hint that its effects may extend beyond boosting NAD+ levels and into the molecular processes that influence how muscle ages over time [1]. For the longevity field, that’s an intriguing shift in focus.
Not all aging happens at the same pace. Scientists increasingly distinguish between chronological age – the number of birthdays you’ve had – and biological age, which reflects how healthy or worn your tissues appear at a molecular level. One way researchers estimate this is through so-called epigenetic clocks, which analyze chemical changes to DNA that accumulate over time. Rather than asking whether people looked or felt younger, this study examined whether muscle tissue itself appeared biologically younger after NR supplementation.
Researchers analyzed skeletal muscle and blood samples collected from three previously published human clinical studies, alongside laboratory experiments in human muscle cells. Instead of relying on a single biological clock, they compared results across seven different epigenetic clocks, including one designed specifically for skeletal muscle.
The researchers found that participants who took 1,000 mg of Niagen NR daily for five months showed an approximately 2.5-year reduction in muscle epigenetic age acceleration using the muscle-specific MEAT clock. Several other clocks also pointed in the same direction, although not every measurement agreed. That inconsistency is important. Rather than presenting one definitive answer, the study reinforces a growing reality in aging research: different biological clocks measure different aspects of aging, and no single test tells the whole story.
Skeletal muscle is about much more than strength. Healthy muscle supports mobility, metabolic health and independence later in life, making it one of the most important tissues for maintaining healthspan. As people age, muscles gradually lose efficiency, in part because the tiny energy-producing structures inside cells – mitochondria – become less effective.
The new analysis found that changes in mitochondrial DNA content were linked with changes in muscle biological age, suggesting that healthier mitochondria and healthier-looking muscle tissue may be connected.
“This is among the first human studies suggesting that Niagen NR supplementation may alter epigenetic aging in skeletal muscle, rather than simply increasing NAD+ or improving mitochondrial function,” said Rob Fried, CEO of Niagen Bioscience. “It strengthens the idea that NAD+ restoration can influence biological aging pathways at the tissue level.”
Senior author Dr Eija Pirinen, from the University of Helsinki and the University of Oulu, struck a more measured tone.
“Our earlier work showed that Niagen NR can enhance muscle mitochondrial health, and this study shows that these benefits may extend to the epigenetic level,” she said. “It is a meaningful step toward understanding how NAD+ restoration may influence molecular markers of aging in human skeletal muscle; however, additional research must be conducted.”
One of the more interesting aspects of the analysis was that it didn’t examine NR in isolation. Researchers also compared data from previous studies involving high-intensity interval training (HIIT). Rather than producing identical effects, exercise and NR appeared to influence biological aging differently depending on which epigenetic clock was used.
In fact, one clock suggested HIIT produced greater improvements than NR, while others favored supplementation. The researchers suggest the two approaches may ultimately prove complementary rather than competing, although dedicated studies testing them together will be needed. That reflects an increasingly nuanced view emerging across longevity science: there is unlikely to be a single intervention capable of addressing every hallmark of aging.
The findings add momentum to a rapidly expanding area of longevity research focused on measuring biological aging instead of simply treating age-related disease. They also highlight how the field itself is evolving. Researchers are moving beyond asking whether an intervention boosts a particular molecule and instead exploring whether it changes the biological processes associated with aging in specific tissues.
At the same time, the authors are careful not to overstate the results. This was an analysis of samples from previously completed studies rather than a newly designed clinical trial, meaning the findings should be viewed as encouraging rather than conclusive.
Still, as biological clocks become increasingly sophisticated and muscle health continues to emerge as a cornerstone of healthy aging, studies like this help sharpen an important question for the longevity sector: not just whether interventions can raise NAD+, but whether they can meaningfully influence the pace at which our tissues age.
For an industry searching for reliable biomarkers that can accelerate the development of longevity therapies, that may prove to be one of the most significant advances of all. For us all.
